22 Oct

Group of leading academics say Humira patent thicketing antitrust issues must be looked at again

66 professors are seeking the reversal of a district court decision, following the dismissal of a potential landmark dispute over AbbVie's IP strategy and the nature of sham litigation.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth